These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9600824)

  • 21. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cervical cancer before 35 years of age: epidemiological and prognostic aspects. Retrospective study of 46 cases of cervical cancer before 35 years of age in a series of 449 cases in stages IA2 and IV].
    Saint-Paul MT; Brémond A; Rochet Y
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):737-42. PubMed ID: 8308199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
    Tsai CC; Liu YS; Huang EY; Huang SC; Chang HW; Tseng CW; ChangChien CC
    Gynecol Oncol; 2006 Mar; 100(3):591-5. PubMed ID: 16290001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
    Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
    Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features and treatment of cervical malignant tumor in young women].
    Zhang Y; Shen K; Gao JS; Wu M; Huang HF; Pan LY; Lang JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):391-5. PubMed ID: 12974080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium.
    Lurain JR; Rice BL; Rademaker AW; Poggensee LE; Schink JC; Miller DS
    Obstet Gynecol; 1991 Jul; 78(1):63-9. PubMed ID: 2047070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
    Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
    Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up results of irradiation alone or combined with surgery in stage I-IV carcinoma of the uterine cervix.
    Reinartz G; Bartsch S; Willich N
    Zentralbl Gynakol; 2000; 122(6):318-23. PubMed ID: 10904995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix.
    Kasamatsu T; Onda T; Sasajima Y; Kato T; Ikeda S; Ishikawa M; Tsuda H
    Gynecol Oncol; 2009 Dec; 115(3):488-92. PubMed ID: 19767067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
    Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.